According to Vertess, an international healthcare-focused M + A advisory firm with expertise in diverse healthcare and human service verticals, ranging from healthcare IT to life sciences and other specialized services and products, every sector of the healthcare industry is struggling to figure out what TrumpCare will mean to their businesses. Some will do better under TrumpCare, but most will do worse. There is one sector, however, which is guaranteed to grow like gangbusters under a Trump administration: Healthcare IT. Vertess explains why.
Medtronic plc announced that its coronary portfolio will now include the DxTerity Diagnostic Angiography Catheter line and several transradial-specific products. Additional products include the DxTerity TRA, InTRAkit access kit and TRAcelet compression device, all of which received U.S. Food and Drug Administration (FDA) clearance and CE (Conformité Européenne) Mark for use in diagnostic cardiac catheterization procedures and percutaneous coronary intervention (PCI).
Levels of a protein in the blood associated with heart disease are also linked to early-stage brain damage, according to a study appearing online in the journal Radiology.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sempra 60-cm 1.5 Tesla (1.5T) magnetic resonance imaging (MRI) system.
The supplies you use in your cath lab are complex and very valuable. Protecting your investment and uncovering new ...
February 16, 2017 — New recommendations for healthcare providers, published in the American Heart Association journal ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
People are living longer today; however, the older a person is, the higher the risk of cardiovascular disease, heart attack or stroke. Despite this fact, prevention guidelines for cardiovascular events are the least aggressive for those 75 years and above due to limited clinical data. Researchers at Baylor College of Medicine and Johns Hopkins University are using data from the long-term study Atherosclerosis Risk in Communities (ARIC) to pinpoint the best recommendations for prediction, treatment and prevention for the aging population.
Western Connecticut Health Network (WCHN) cardiothoracic surgeons Cary Passik, M.D., and Robert Gallagher, M.D., were the first in Connecticut to implant the Edwards Intuity Elite sutureless aortic valve in two patients at Danbury Hospital. This new technology in aortic valve replacement (AVR) surgery presents a safe and effective option for patients with severe aortic valve disease. The valves were implanted using the Edwards Intuity valve system, a rapid deployment device approved by the U.S. Food and Drug Administration (FDA) in August 2016.
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter for treating patients with atrioventricular nodal re-entrant tachycardia (AVNRT), a life- threatening abnormal heart rhythm.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 15, 2017 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of GSI Xtream on ...
February 15, 2017 — Deep learning, also known as artificial intelligence, will increasingly be used in the ...
Mercator MedSystems announced that the national co-principal investigators of the company’s DANCE trial each presented comprehensive 13-month trial data during Late-Breaking sessions at ISET (International Symposium on Endovascular Therapy) in Hollywood, Fla., and LINC (Leipzig Interventional Course) in Leipzig, Germany.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Better hospital supply chain management leads to better quality of care and supports patient safety, according to a new Cardinal Health survey of hospital staff and decision makers. Despite respondents rating their supply chain processes as “good,” one in four hospital staff have seen or heard of expired product being used on a patient, and 18 percent have seen or heard of a patient being harmed due to a lack of necessary supplies.
Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug Administration (FDA)-approved patent foramen ovale occluder in Alabama.
The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U.S. Food and Drug Administration (FDA) approval utilizing results from the BIOHELIX-I clinical study. This stent, which has already been used to treat more than 650,000 patients worldwide, is now available in the United States.